Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

García Rodríguez LA, Lagergren J, Lindblad M.

Gut. 2006 Nov;55(11):1538-44. Epub 2006 Jun 19.

PMID:
16785284
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.

Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow WH, Risch HA, Stanford JL, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West AB, Dubrow R, Fraumeni JF Jr, Blot WJ.

Cancer Causes Control. 2000 Mar;11(3):231-8.

PMID:
10782657
[PubMed - indexed for MEDLINE]
3.

Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.

Duan L, Wu AH, Sullivan-Halley J, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):526-33. doi: 10.1158/1055-9965.EPI-08-0764. Epub 2009 Feb 3.

PMID:
19190141
[PubMed - indexed for MEDLINE]
Free Article
4.

Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.

Vaughan TL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):749-56.

PMID:
9752982
[PubMed - indexed for MEDLINE]
Free Article
5.

Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.

Wu AH, Tseng CC, Bernstein L.

Cancer. 2003 Sep 1;98(5):940-8.

PMID:
12942560
[PubMed - indexed for MEDLINE]
Free Article
6.

H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.

Suleiman UL, Harrison M, Britton A, McPherson K, Bates T.

Eur J Cancer Prev. 2000 Jun;9(3):185-91.

PMID:
10954258
[PubMed - indexed for MEDLINE]
7.

Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia.

Freedman J, Lagergren J, Bergström R, Näslund E, Nyrén O.

Br J Surg. 2000 Aug;87(8):1087-93.

PMID:
10931056
[PubMed - indexed for MEDLINE]
8.

Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.

Lindblad M, Rodríguez LA, Lagergren J.

Cancer Causes Control. 2005 Apr;16(3):285-94.

PMID:
15947880
[PubMed - indexed for MEDLINE]
9.

Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.

Chandanos E, Lindblad M, Jia C, Rubio CA, Ye W, Lagergren J.

Br J Cancer. 2006 Jul 3;95(1):118-22. Epub 2006 Jun 6.

PMID:
16755290
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.

Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1154-1159.e3. Epub 2007 Jul 23.

PMID:
17644046
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.

Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyrén O.

J Natl Cancer Inst. 2004 Mar 3;96(5):388-96.

PMID:
14996860
[PubMed - indexed for MEDLINE]
Free Article
12.

Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.

Ladanchuk TC, Johnston BT, Murray LJ, Anderson LA; FINBAR study group.

Scand J Gastroenterol. 2010 Dec;45(12):1397-403. doi: 10.3109/00365521.2010.503968. Epub 2010 Jul 14.

PMID:
20626305
[PubMed - indexed for MEDLINE]
13.

Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma.

Jansson C, Plato N, Johansson AL, Nyrén O, Lagergren J.

Occup Environ Med. 2006 Feb;63(2):107-12.

PMID:
16421388
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).

González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, Ferrari P, Boeing H, del Giudice G, Plebani M, Carneiro F, Nesi G, Berrino F, Sacerdote C, Tumino R, Panico S, Berglund G, Simán H, Nyrén O, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Day NE, Linseisen J, Nagel G, Bergmann MM, Overvad K, Jensen MK, Tjonneland A, Olsen A, Bueno-de-Mesquita HB, Ocke M, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Trichopoulou A, Psaltopoulou T, Roukos D, Lund E, Hemon B, Kaaks R, Norat T, Riboli E.

J Natl Cancer Inst. 2006 Mar 1;98(5):345-54.

PMID:
16507831
[PubMed - indexed for MEDLINE]
Free Article
15.

Mortality study of 18 000 patients treated with omeprazole.

Bateman DN, Colin-Jones D, Hartz S, Langman M, Logan RF, Mant J, Murphy M, Paterson KR, Rowsell R, Thomas S, Vessey M; SURVEIL (Study of Undetected Reactions, Vigilance Enquiry into Links) Group.

Gut. 2003 Jul;52(7):942-6.

PMID:
12801948
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.

Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr.

JAMA. 1995 Aug 9;274(6):474-7.

PMID:
7629956
[PubMed - indexed for MEDLINE]
17.

Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.

Tamim H, Duranceau A, Chen LQ, Lelorier J.

Drug Saf. 2008;31(8):675-84.

PMID:
18636786
[PubMed - indexed for MEDLINE]
18.

Acid inhibitory medication and risk of gastric and oesophageal cancer.

McColl KE.

Gut. 2006 Nov;55(11):1532-3. Review. No abstract available.

PMID:
17047103
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.

Gerson LB, Boparai V, Ullah N, Triadafilopoulos G.

Aliment Pharmacol Ther. 2004 Sep 15;20(6):637-43.

PMID:
15352912
[PubMed - indexed for MEDLINE]
Free Article
20.

Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Nagel G, Linseisen J, Boshuizen HC, Pera G, Del Giudice G, Westert GP, Bueno-de-Mesquita HB, Allen NE, Key TJ, Numans ME, Peeters PH, Sieri S, Siman H, Berglund G, Hallmans G, Stenling R, Martinez C, Arriola L, Barricarte A, Chirlaque MD, Quiros JR, Vineis P, Masala G, Palli D, Panico S, Tumino R, Bingham S, Boeing H, Bergmann MM, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Olsen A, Tjonneland A, Trichopoulou A, Bamia C, Soukara S, Sabourin JC, Carneiro F, Slimani N, Jenab M, Norat T, Riboli E, González CA.

Int J Epidemiol. 2007 Feb;36(1):66-76. Epub 2007 Jan 16.

PMID:
17227779
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk